Kisspeptin · research summary

Hyperkisspeptinemia and hypothalamic-pituitary-gonadal axis uncoupling in hemodialysis patients: clinical evidence suggestive of central desensitization.

Clinical kidney journal · 2026. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.

Study type

Cross-sectional case-control study
“This observational, cross-sectional case–control study was conducted at the hemodialysis center of Naval Medical Center of PLA, Shanghai, China between November 2025 and March 2026.”

Subjects

Patients undergoing maintenance hemodialysis and age-matched healthy controls
“In this cross-sectional study, 69 MHD patients and 20 age-matched healthy controls (HCs) were recruited.”

Sample size

89 participants (69 MHD patients and 20 healthy controls)
“a final cohort of 69 MHD patients and 20 age-matched HCs was included in the final analysis.”

Duration

Data collection occurred between November 2025 and March 2026
“This observational, cross-sectional case–control study was conducted at the hemodialysis center of Naval Medical Center of PLA, Shanghai, China between November 2025 and March 2026.”

Reported findings

Serum kisspeptin levels were significantly higher in maintenance hemodialysis patients compared to healthy controls.
“Serum kisspeptin was profoundly elevated in MHD patients versus HCs (median, 30.35 vs 9.02 ng/ml; P < .001).”
In uremic females, gonadotropin levels did not significantly differ from healthy controls despite elevated kisspeptin and hypoestrogenism.
“In uremic females, despite profound hypoestrogenism and massive kisspeptin stimuli, compensatory gonadotropin surges were blunted (follicle-stimulating hormone: P = .138; luteinizing hormone: P = .149), suggesting potential pituitary desensitization.”
Mediation analysis indicated that the association between kisspeptin and erectile dysfunction in males was mediated by testosterone.
“Mediation analysis revealed a mediation pattern consistent with testosterone-mediated effects of kisspeptin’s impact on erectile function (indirect effect P = .046; direct effect P = .081), suggesting that kisspeptin accumulation may be associated with ED exclusively by suppressing the HPG axis.”

Limitations stated by the authors

The study had a modest sample size, cross-sectional design preventing causal inference, and lacked dynamic endocrine stimulation testing.
“First, the modest sample size, inherently limited by our strict single-center inclusion criteria (designed to minimize inflammatory and primary gonadal confounders), may reduce statistical power. Second, the cross-sectional design inherently precludes definitive causal inference.”

Source: PubMed 42571597 · DOI 10.1093/ckj/sfag238 · all study summaries

Reported findings

Serum kisspeptin levels were significantly higher in maintenance hemodialysis patients compared to healthy controls.

“Serum kisspeptin was profoundly elevated in MHD patients versus HCs (median, 30.35 vs 9.02 ng/ml; P < .001).”

In uremic females, gonadotropin levels did not significantly differ from healthy controls despite elevated kisspeptin and hypoestrogenism.

“In uremic females, despite profound hypoestrogenism and massive kisspeptin stimuli, compensatory gonadotropin surges were blunted (follicle-stimulating hormone: P = .138; luteinizing hormone: P = .149), suggesting potential pituitary desensitization.”

Mediation analysis indicated that the association between kisspeptin and erectile dysfunction in males was mediated by testosterone.

“Mediation analysis revealed a mediation pattern consistent with testosterone-mediated effects of kisspeptin’s impact on erectile function (indirect effect P = .046; direct effect P = .081), suggesting that kisspeptin accumulation may be associated with ED exclusively by suppressing the HPG axis.”

Limitations stated by the authors

The study had a modest sample size, cross-sectional design preventing causal inference, and lacked dynamic endocrine stimulation testing.

“First, the modest sample size, inherently limited by our strict single-center inclusion criteria (designed to minimize inflammatory and primary gonadal confounders), may reduce statistical power. Second, the cross-sectional design inherently precludes definitive causal inference.”